Expert guides on retatrutide, semaglutide, and melanotan 2 — dosing protocols, reconstitution, and comparisons for European researchers.
Latest retatrutide clinical trial data, Phase 2 results showing 24.2% mean weight loss, and how it compares to semaglutide and tirzepatide. Essential reading for metabolic researchers.
Read Full Analysis →Complete guide to retatrutide dosing protocols, reconstitution, storage, and research applications for the GLP-1/GIP/GCGR triple agonist.
Expert comparison of top research peptides available in Europe — purity standards, sourcing, pricing, and where to find HPLC-tested compounds.
In-depth comparison of mechanism of action, efficacy data, dosing protocols, and research applications to help you choose the right peptide.
Complete practical guide: bacteriostatic vs sterile water, dosing calculations, storage tips, and best practices for accurate, reproducible research.
Latest Phase 2 trial data, 24.2% mean weight loss findings, and researcher-reported outcomes on this triple agonist GLP-1/GIP/GCGR peptide.
Comprehensive Melanotan 2 dosing for researchers: loading protocols, maintenance phases, reconstitution, light protection, and best practices.
≥98% purity, HPLC tested, COA included. Ships across Europe in discreet packaging.